Hospital Anxiety and Depression Scale

Assessing Quality of Life in the Treatment of Patients With Age-Related Macular Degeneration: Clinical Research Findings and Recommendations for Clinical Practice.

Assessing quality of life in the treatment of patients with age-related macular degeneration: clinical research findings and recommendations for clinical practice.

Clin Ophthalmol. 2013; 7: 1325-32
Yuzawa M, Fujita K, Tanaka E, Wang EC

The importance of incorporating quality-of-life… Continue reading →

Perception of Chronic Respiratory Impairment in Patients’ Drawings.

Perception of chronic respiratory impairment in patients’ drawings.

J Rehabil Med. 2013 Jun 24;
Luthy C, Cedraschi C, Pasquina P, Uldry C, Junod-Perron N, Janssens JP

Objective: To explore the perception of dyspnoea in patients with severe chronic obstructive… Continue reading →

Safety, Anxiety and Natalizumab Continuation in JC Virus-Seropositive MS Patients.

Safety, anxiety and natalizumab continuation in JC virus-seropositive MS patients.

Mult Scler. 2013 Jul 4;
van Rossum JA, Vennegoor A, Balk L, Uitdehaag BM, Polman CH, Killestein J

The use of natalizumab in multiple sclerosis has been restricted by… Continue reading →

Effect of a Local Vibration Stimulus Training Programme on Postural Sway and Gait in Chronic Stroke Patients: A Randomized Controlled Trial.

Effect of a local vibration stimulus training programme on postural sway and gait in chronic stroke patients: a randomized controlled trial.

Clin Rehabil. 2013 Jul 1;
Lee SW, Cho KH, Lee WH

Objective:To investigate the effect of a local… Continue reading →

Qualitative Study of the Quality of Sleep in Marginalized Individuals Living With HIV.

Qualitative study of the quality of sleep in marginalized individuals living with HIV.

Patient Prefer Adherence. 2013; 7: 499-507
Saberi P, Comfort M, Sheon N, Johnson MO

Sleep disturbances have been reported to be higher in human immunodeficiency virus… Continue reading →

Daily Oral Ketamine for the Treatment of Depression and Anxiety in Patients Receiving Hospice Care: A 28-Day Open-Label Proof-of-Concept Trial.

Daily Oral Ketamine for the Treatment of Depression and Anxiety in Patients Receiving Hospice Care: A 28-Day Open-Label Proof-of-Concept Trial.

J Palliat Med. 2013 Jun 27;
Irwin SA, Iglewicz A, Nelesen RA, Lo JY, Carr CH, Romero SD, Lloyd… Continue reading →

Measurement of Distress and Its Alteration During Treatment in Nasopharyngeal Carcinoma Patients.

Measurement of distress and its alteration during treatment in nasopharyngeal carcinoma patients.

Head Neck. 2013 Jun 26;
Deng YT, Zhong WN, Jiang Y

Background: We examined the criterion-related validity of the Distress Thermometer (DT) for screening distress in nasopharyngeal… Continue reading →

[CARDIOHEMODYNAMIC FEATURES and CHARACTER of DEPRESSIVE DISORDERS in PATIENTS WITH ANEMIA VARYING GRADES of SEVERITY WITH CHRONIC HEART FAILURE and CHRONIC KIDNEY DISEASE.]

[CARDIOHEMODYNAMIC FEATURES AND CHARACTER OF DEPRESSIVE DISORDERS IN PATIENTS WITH ANEMIA VARYING GRADES OF SEVERITY WITH CHRONIC HEART FAILURE AND CHRONIC KIDNEY DISEASE.]

Georgian Med News. 2013 May; 40-44
Ryndina N, Kravchun P, Tytova G, Liepieieva O

Anemia and… Continue reading →

Functional Electrical Stimulation Increases Neural Stem/progenitor Cell Proliferation and Neurogenesis in the Subventricular Zone of Rats With Stroke.

Functional electrical stimulation increases neural stem/progenitor cell proliferation and neurogenesis in the subventricular zone of rats with stroke.

Chin Med J (Engl). 2013 Jun; 126(12): 2361-2367
Liu HH, Xiang Y, Yan TB, Tan ZM, Li SH, He XK

Functional… Continue reading →

Decynium-22 Enhances SSRI-Induced Antidepressant-Like Effects in Mice: Uncovering Novel Targets to Treat Depression.

Decynium-22 Enhances SSRI-Induced Antidepressant-Like Effects in Mice: Uncovering Novel Targets to Treat Depression.

J Neurosci. 2013 Jun 19; 33(25): 10534-43
Horton RE, Apple DM, Owens WA, Baganz NL, Cano S, Mitchell NC, Vitela M, Gould GG, Koek W, Daws… Continue reading →